FDA approves CPR devices
On March 9 the U.S. Food and Drug Administration (FDA) approved the ResQCPR System, a system of two devices for first responders to use…
Web Exclusives
FDA approves first therapy for high-risk neuroblastoma
On March 10, the U.S. Food and Drug Administration (FDA) approved Unituxin (dinutuximab) as part of first-line therapy for pediatric patients with high-risk neuroblastoma.…
FDA launches drug shortages app
On March 4, the U.S. Food and Drug Administration (FDA) launched a free mobile app that identifies current drug shortages, resolved shortages, and discontinuations…
Associate degree nurses shifting to long-term care
According to a study in Nursing Economics, many nurses with associate degrees who would have otherwise been employed in hospitals seem to have shifted…
Bariatric surgery safe option for pediatric population
Bariatric surgery doesn’t stunt the growth of obese children and adolescents when applied within a clinical pathway and is a safe option for those…
FDA approves system to permanently treat varicose veins
On February 20, the U.S. Food and Drug Administration (FDA) approved he VenaSeal closure system (VenaSeal system) to permanently treat varicose veins of the…
FDA approves Farydak for treatment of multiple myeloma
On February 23, the U.S. Food and Drug Administration (FDA) approved Farydak (panobinostat) for the treatment of patients with multiple myeloma. Read more.
Football helmet add-ons may not significantly reduce concussion risk
Football helmet add-ons such as outer soft-shell layers, spray treatments, helmet pads and fiber sheets may not significantly help lower the risk of concussions…
FDA approves new drug for thyroid cancer
On February 13, the U.S. Food and Drug Administration (FDA) approved Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer whose disease progressed…
Exercise for patients with type 2 diabetes most effective after dinner
Performing resistance exercise to reduce the risk of cardiovascular disease in obese patients with type 2 diabetes is most effective when done after dinner,…
New HPV vaccine offers greater protection against cervical cancer
A study in The New England Journal of Medicine Scientists reports that a new HPV (human papilloma virus) vaccine protects against nine types of…
FDA approves Lucentis to treat diabetic retinopathy
On February 6, the U.S. Food and Drug Administration (FDA) expanded the approved use for Lucentis (ranibizumab injection) 0.3 mg to treat diabetic retinopathy…
FDA approves CPR devices
On March 9 the U.S. Food and Drug Administration (FDA) approved the ResQCPR System, a system of two devices for first responders…
FDA approves first therapy for high-risk neuroblastoma
On March 10, the U.S. Food and Drug Administration (FDA) approved Unituxin (dinutuximab) as part of first-line therapy for pediatric patients with…
FDA launches drug shortages app
On March 4, the U.S. Food and Drug Administration (FDA) launched a free mobile app that identifies current drug shortages, resolved shortages,…
Associate degree nurses shifting to long-term care
According to a study in Nursing Economics, many nurses with associate degrees who would have otherwise been employed in hospitals seem to…
Bariatric surgery safe option for pediatric population
Bariatric surgery doesn’t stunt the growth of obese children and adolescents when applied within a clinical pathway and is a safe option…
FDA approves system to permanently treat varicose veins
On February 20, the U.S. Food and Drug Administration (FDA) approved he VenaSeal closure system (VenaSeal system) to permanently treat varicose veins…
FDA approves Farydak for treatment of multiple myeloma
On February 23, the U.S. Food and Drug Administration (FDA) approved Farydak (panobinostat) for the treatment of patients with multiple myeloma. Read…
Football helmet add-ons may not significantly reduce concussion risk
Football helmet add-ons such as outer soft-shell layers, spray treatments, helmet pads and fiber sheets may not significantly help lower the risk…
FDA approves new drug for thyroid cancer
On February 13, the U.S. Food and Drug Administration (FDA) approved Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer whose…
Exercise for patients with type 2 diabetes most effective after dinner
Performing resistance exercise to reduce the risk of cardiovascular disease in obese patients with type 2 diabetes is most effective when done…
New HPV vaccine offers greater protection against cervical cancer
A study in The New England Journal of Medicine Scientists reports that a new HPV (human papilloma virus) vaccine protects against nine…
FDA approves Lucentis to treat diabetic retinopathy
On February 6, the U.S. Food and Drug Administration (FDA) expanded the approved use for Lucentis (ranibizumab injection) 0.3 mg to treat…
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.